Navigation Links
ForteBio Announces Launch of Protein G Biosensor for Use on Company's Octet® Instruments
Date:9/3/2010

uantitation by eliminating throughput and time-to-result limitations of traditional SPR-based assays and ELISA. The Octet biosensors are disposable, configured in a standard microplate format and are coated with a proprietary biocompatible matrix that is uniform, non-denaturing and has minimal non-specific binding.

To date over 2.5 million biosensor assays have been run on Octet systems, a testament to the high reproducibility, accuracy and robustness of the platform.

The company also announced that its biosensor manufacturing facility is now ISO 9001:2008-certified, underscoring the quality of its products.

ABOUT FORTEBIO, INC.ForteBio is a life science company that provides analytical systems to accelerate biotherapeutic drug discovery and development. These systems enable real-time, label-free analysis of biomolecular interactions, providing information on affinity, kinetics and concentration. ForteBio's analytical capabilities enable significantly easier, faster and better characterization of drug candidates, thus providing greater value in drug development applications where existing methods have limitations in throughput, performance and cost. The company is headquartered in Menlo Park, California, with wholly owned subsidiaries in London and Shanghai. For more information, visit www.fortebio.com. Contact: Gemma Milan650-289-6800gmilan@fortebio.com
'/>"/>

SOURCE ForteBio, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ForteBio Launches New Dip and Read(TM) Residual Protein A Detection Kit; Introduces Sidekick(TM) Offline Biosensor Immobilization Station for All Octet(R) Instruments
2. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
3. Nutraceutical Leader Announces Internal Promotions of Key Personnel
4. United American Healthcare Corporation Announces Increase in Board Size and New Director Nominees
5. Ellman International Announces Executive Team Hire
6. Yongye International Announces RMB 400 Million Revolving Credit Facilities
7. QRxPharma Announces Interim Analysis of Final Pivotal Phase 3 Study for MoxDuo®IR
8. Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical Trial of AGS-16M8F for Renal Cancer
9. Golden Meditech Announces Plan to Issue Taiwan Depository Receipts
10. Accuray Announces Results for Fourth Quarter and Fiscal Year 2010
11. Shire Announces Support for Inflammatory Bowel Disease (IBD) Fellowships at Leading Medical Institutions Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... , July 20, 2015 ... has announced the addition of the "Cardiometabolic ... Afrezza,s discounted pricing is in line ... is critical to the product,s commercial appeal. However, ... prevent Afrezza from gaining a sizeable share of ...
(Date:7/27/2015)... WASHINGTON , July 27, 2015 Even ... Larkin , MD, FACP, NCMP, as scientific co-chair for ... health coalition to serve as an expert voice in ... treatment options for women struggling with Hypoactive Sexual Desire ... "I am honored to join Even ...
(Date:7/27/2015)... , July 20, 2015 Research and ... of the "D-dimer Testing Market - Global ... Forecast 2014 - 2022" report to their ... vitro diagnostics market is one of the fastest ... attributed to the improved health care awareness, preference ...
Breaking Medicine Technology:Cardiometabolic Drug News Issue - Afrezza Aggressive Pricing Strategy View Playing Out 2Cardiometabolic Drug News Issue - Afrezza Aggressive Pricing Strategy View Playing Out 3Dr. Lisa Larkin Joins the Even the Score Coalition as Scientific Co-Chair 2Dr. Lisa Larkin Joins the Even the Score Coalition as Scientific Co-Chair 3D-dimer Testing Market - Global Industry Analysis 2015 2D-dimer Testing Market - Global Industry Analysis 2015 3
... (Nasdaq: VOLC ) today announced its intention to ... principal amount of convertible senior notes due September 1, 2015 ... as amended (the "Securities Act"). Prior to June 1, 2015, ... conversion, holders will receive up to the principal amount of ...
... Inc. (Nasdaq: ANDS ) announced today that it ... Friday, September 17, 2010 at 8:35 a.m. EDT (5:35 a.m. ... in Boston.  Steve Worland, Ph.D., President and Chief Executive Officer ... clinical development programs. Dr. Worland will also present ...
Cached Medicine Technology:Volcano Corporation to Offer $100 Million Convertible Senior Notes Due 2015 2Volcano Corporation to Offer $100 Million Convertible Senior Notes Due 2015 3Volcano Corporation to Offer $100 Million Convertible Senior Notes Due 2015 4Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences 2
(Date:7/27/2015)... ... July 27, 2015 , ... Specific cardiovascular risk factors, ... brain volumes that may be early indicators of Alzheimer’s disease and dementia, according ... that vascular risk factors damage the brain and can result in cognitive impairment,” ...
(Date:7/27/2015)... ... July 28, 2015 , ... The National Association of Professional ... VIP Woman of the Year Circle. She is recognized with this prestigious distinction for ... boasting more than 700,000 members and over 200 operating Local Chapters. , “I’m pleased ...
(Date:7/27/2015)... ... July 28, 2015 , ... ... as a 2015 Professional Woman of the Year. Ms. Baum-Lappe is recognized ... organization of professional women in the country, spanning virtually every industry and profession, ...
(Date:7/27/2015)... NC (PRWEB) , ... July 27, 2015 , ... The ... the country, reported WCNC on July 7th. The rate for heroin usage ... heroin has gone down considerably, and is a less expensive alternative for those with ...
(Date:7/27/2015)... ... July 27, 2015 , ... The FSH Society , ... disease, facioscapulohumeral muscular dystrophy (FSHD), today announced the introduction of the first-ever care ... guideline is published today. , This new guideline condenses the results of ...
Breaking Medicine News(10 mins):Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 2Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 3Health News:NAPW Inducts Joanne Saniewski, Principal of the Frontier School District's Big Tree Elementary, Into its VIP Woman of the Year Circle 2Health News:NAPW Inducts Gilda Baum-Lappe, Journalist / Correspondent of Hollywood Foreign Press Association Into its VIP Woman of the Year Circle 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 3Health News:First-Ever FSHD Evidence-based Care Guideline Published by the American Academy of Neurology 2
... Goodwin HealthDay Reporter , MONDAY, Dec. 20 (HealthDay ... histamine-2 receptor antagonists, may raise the risk of pneumonia, new ... 31 studies on heartburn drugs published between 1985 and 2009. ... suppressive drugs is associated with an increased risk of pneumonia," ...
... Horses are prone to develop genital cancer, especially as they ... mares but both sexes suffer from the condition, which is ... death. Because of the similarity of the disease to ... might be responsible. Several human genital cancers, including cervical ...
... advice are more effective than anti-inflammatory drugs and cortisone ... effects. This is the conclusion of a thesis presented ... describes, among other topics, the selection of treatment by ... elbow, and the results from a training programme for ...
... Gothenburg, Sweden, and researchers from the University of Gvle and ... in tests that ovarian cancer tissue and healthy tissue smell ... Future Oncology . In a previous project Gyrgy Horvath ... a specific scent. The dogs were able to use this ...
... Doheny HealthDay Reporter , MONDAY, Dec. 20 (HealthDay ... a new study finds that infants breast-fed for six months ... age 10 compared to bottle-fed tots, according to a new ... girls for its positive benefits," said study leader Wendy Oddy, ...
... SUNDAY, Dec. 19 (HealthDay News) -- Though holiday partying ... to partake moderately. "Research shows that drinking even ... developing cancer, including oral cancer, breast cancer and liver ... Center at the University of Texas M.D. Anderson Cancer ...
Cached Medicine News:Health News:Heartburn Drugs May Raise Pneumonia Risk 2Health News:Heartburn Drugs May Raise Pneumonia Risk 3Health News:A possible cause -- and cure -- for genital cancer in horses? 2Health News:Training the best treatment for tennis elbow 2Health News:Do Breast-Fed Baby Boys Grow Into Better Students? 2Health News:Do Breast-Fed Baby Boys Grow Into Better Students? 3Health News:Keeping Holiday Drinking in Check May Counter Cancer 2
Synchron CX3 Delta is a critical care clinical system, providing unparalleled testing speed for the most frequently ordered chemistries-Glucose, BUN, Creatinine, Sodium, Potassium Chloride, CO2 Calci...
Iron FS Ferene for determination of iron in serum. Available with Calibrator: Trucal U and Controls: Trulab N, Trulab P. For automated systems....
For the quantitative determination of Iron and IBC in serum. Colorimetric method utilizing ferrozine. Endpoint procedure measured at 560 nm. Linearity: 500 ug/dl....
Cholesterol/HDL Standard 50 mg/dl....
Medicine Products: